Cargando…
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies
SIMPLE SUMMARY: In this review article, we present the fascinating story of sirolimus (rapamycin), a drug known to be able to induce fetal hemoglobin, and for this reason of great interest for the treatment of β-thalassemia. In fact, high levels of fetal hemoglobin have been demonstrated to be benef...
Autores principales: | Gambari, Roberto, Zuccato, Cristina, Cosenza, Lucia Carmela, Zurlo, Matteo, Gasparello, Jessica, Finotti, Alessia, Gamberini, Maria Rita, Prosdocimi, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525103/ https://www.ncbi.nlm.nih.gov/pubmed/37759601 http://dx.doi.org/10.3390/biology12091202 |
Ejemplares similares
-
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus
por: Zurlo, Matteo, et al.
Publicado: (2023) -
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
por: Zuccato, Cristina, et al.
Publicado: (2022) -
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study
por: Gamberini, Maria Rita, et al.
Publicado: (2023) -
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β(0)39-thalassemia patients
por: Cosenza, Lucia Carmela, et al.
Publicado: (2021) -
Effects of Sirolimus treatment on patients with β‐Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4
(+) and CD8
(+) T cells
por: Zurlo, Matteo, et al.
Publicado: (2023)